V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270019618 | 270018446 | 1.72 | null | Adjuvant (A) | 2014-05-12 | 2014-05-21 | Bendamustine +/- Prednisolone | 02 | N | 270016761 | BENDAMUSTINE |
| 270019619 | 270014565 | 1.77 | 78.4 | Curative (C) | 2017-10-20 | 2018-01-01 | GDP | N | N | 270016781 | GDP |
| 270019620 | 270009741 | 1.49 | null | Curative (C) | 2014-09-30 | 2014-10-07 | GDP | N | N | 270016783 | GDP |
| 270019621 | 270019247 | 1.75 | 66.9 | Neo-adjuvant (N) | 2015-12-01 | 2015-12-29 | Irinotecan | N | N | 270016786 | IRINOTECAN |
| 270019622 | 270014571 | 0 | 65.3 | Palliative (P) | 2019-03-14 | 2019-03-23 | GEMCITABINE | N | N | 270016804 | BEAM + ALEMTUZUMAB |
| 270019623 | 270009754 | 1.57 | 61.8 | Curative (C) | 2020-03-25 | 2020-03-25 | Irinotecan 14day | N | null | 270016828 | IRINOTECAN |
| 270019624 | 270014577 | 1.8 | 91.5 | Curative (C) | 2015-02-28 | 2015-03-02 | Oxaliplatin + Raltitrexed | 2 | N | 270016872 | CISPLATIN |
| 270019625 | 270014578 | null | 74.9 | null | 2017-01-29 | 2017-01-30 | GDP | N | N | 270016880 | GDP |
| 270019626 | 270018453 | 1.74 | 59 | Curative (C) | 2019-08-05 | 2019-08-05 | Irinotecan | N | N | 270016905 | IRINOTECAN |
| 270019627 | 270009782 | 1.72 | 59 | Curative (C) | 2016-08-14 | 2016-08-19 | IVE | 02 | N | 270016922 | IVE |
| 270019628 | 270017049 | 1.79 | 57.6 | Curative (C) | null | 2017-06-02 | BEAM + Alemtuzumab Allo SCT | N | N | 270016939 | GEMCITABINE + IFOSFAMIDE + VINORELBINE |
| 270019629 | 270009788 | 1.77 | 60.8 | null | 2016-06-27 | 2016-06-30 | GEM-P | N | N | 270016950 | GEMCITABINE + PACLITAXEL |
| 270019630 | 270009806 | 1.66 | 52.8 | Curative (C) | 2019-02-20 | 2019-02-27 | NIVOLUMAB | N | N | 270016989 | ABVD R |
| 270019631 | 270014595 | null | null | Curative (C) | null | 2018-04-06 | Carboplatin AUC 2 - 5 | N | N | 270016997 | NIVOLUMAB |
| 270019632 | 270009821 | 1.6 | 36.8 | Adjuvant (A) | 2014-08-14 | 2014-08-15 | ABVD R | N | N | 270017016 | CISPLATIN |
| 270019633 | 270009827 | 1.8 | null | Curative (C) | 2016-09-02 | 2016-10-21 | VEPEMB | N | N | 270017022 | GEMCITABINE + IFOSFAMIDE + VINORELBINE |
| 270019634 | 270009833 | 1.78 | 83 | Palliative (P) | 2017-04-19 | 2017-04-25 | CISPLATIN + GEMCITABINE | 2 | N | 270017039 | CISPLATIN + GEMCITABINE |
| 270019635 | 270009836 | 1.86 | null | Palliative (P) | 2016-03-26 | 2016-03-27 | BENDAMUSTINE | 2 | N | 270017044 | BENDAMUSTINE |
| 270019636 | 270009844 | null | 85.6 | null | 2016-08-24 | 2016-08-31 | IVE | 02 | N | 270017056 | IVE |
| 270019637 | 270009849 | 1.72 | 74.6 | Curative (C) | 2018-11-08 | 2018-11-09 | CISPLATIN + GEMCITABINE | 02 | N | 270017063 | AFLIBERCEPT + FU + IRINOTECAN |
| 270019638 | 270009871 | 1.8 | 78.4 | Curative (C) | 2019-05-22 | 2019-05-22 | Cyclophosphamide High Dose | N | N | 270017117 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 270019639 | 270009904 | 0 | 77.2 | Curative (C) | 2014-11-02 | 2015-03-05 | Oxaliplatin + Raltitrexed | 02 | null | 270017233 | PANITUMUMAB |
| 270019640 | 270009920 | 1.6 | 76 | null | 2013-06-17 | 2013-11-20 | Cisplatin | N | null | 270017260 | VEPEMB |
| 270019641 | 270009926 | 1.66 | 100.4 | Adjuvant (A) | 2017-01-11 | 2017-02-04 | IGEV | N | N | 270017261 | NIVOLUMAB |
| 270019642 | 270009934 | 1.73 | null | Curative (C) | 2016-07-06 | 2016-08-04 | CISPLATIN + GEMCITABINE | N | N | 270017276 | AFLIBERCEPT + FU + IRINOTECAN |
| 270019643 | 270009935 | 1.8 | null | Curative (C) | 2015-09-25 | 2015-10-27 | IGEV | 02 | null | 270017287 | NIVOLUMAB |
| 270019644 | 270009937 | 1.8 | null | Palliative (P) | 2016-07-25 | 2016-08-09 | Cyclophosphamide High Dose | 2 | N | 270017290 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 270019645 | 270009954 | 1.72 | -1 | Curative (C) | 2017-10-21 | 2018-01-01 | Cyclophosphamide High Dose | N | N | 270017306 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 270019646 | 270009959 | null | 133.5 | Curative (C) | 2015-07-06 | 2015-07-13 | Vinblastine | N | N | 270017315 | NIVOLUMAB |
| 270019647 | 270009965 | 1.72 | 54.2 | Palliative (P) | 2015-11-27 | 2015-12-03 | BENDAMUSTINE | 02 | null | 270017328 | BENDAMUSTINE |
| 270019648 | 270009969 | 1.73 | 75.4 | Curative (C) | 2017-05-17 | 2018-03-09 | IVE | 2 | N | 270017330 | IVE |
| 270019649 | 270009973 | 1.62 | 46 | Curative (C) | 2016-04-13 | 2016-06-24 | Panitumumab | N | N | 270017331 | OXALIPLATIN + RALTITREXED |
| 270019650 | 270017093 | 1.78 | 72.2 | Curative (C) | 2018-08-31 | 2019-06-23 | AFLIBERCEPT + FU + IRINOTECAN | N | N | 270017379 | VINBLASTINE |
| 270019651 | 270009992 | 1.83 | null | Adjuvant (A) | 2017-02-26 | 2017-04-03 | Irinotecan 14day | 02 | N | 270017382 | IRINOTECAN |
| 270019652 | 270009998 | 1.54 | 33.4 | Palliative (P) | 2018-10-22 | 2018-11-02 | IVE | N | null | 270017404 | IVE |
| 270019653 | 270018476 | 1.68 | null | Palliative (P) | 2019-07-15 | 2019-09-16 | Cyclophosphamide High Dose | N | null | 270017410 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 270019654 | 270019263 | 1.8 | 78 | Curative (C) | 2017-02-05 | 2017-02-05 | BENDAMUSTINE | N | N | 270017427 | BENDAMUSTINE |
| 270019655 | 270010016 | 1.82 | 76.2 | Palliative (P) | 2015-10-28 | 2015-11-19 | IGEV | N | N | 270017431 | BEVACIZUMAB |
| 270019657 | 270010023 | 1.78 | 74 | Adjuvant (A) | 2014-03-28 | 2014-04-05 | ABVD R | N | N | 270017436 | NIVOLUMAB |
| 270019658 | 270010026 | 1.58 | 77.4 | Curative (C) | 2018-11-15 | 2019-01-10 | ABVD R | N | N | 270017438 | CISPLATIN |
| 270019659 | 270010032 | null | 85.6 | Adjuvant (A) | null | 2018-05-03 | ABVD R | 02 | N | 270017456 | AFLIBERCEPT + FU + IRINOTECAN |
| 270019660 | 270010038 | 1.36 | 65.6 | null | 2015-11-20 | 2015-11-26 | Cisplatin | N | N | 270017468 | VINBLASTINE |
| 270019661 | 270010041 | 1.7 | 100 | Adjuvant (A) | 2017-06-03 | 2017-06-07 | Cisplatin | N | N | 270017469 | CETUXIMAB + OXALIPLATIN + MDG |
| 270019663 | 270014694 | 1.67 | 69.5 | Curative (C) | 2017-07-22 | 2017-08-02 | Panitumumab | N | N | 270017488 | CISPLATIN |
| 270019664 | 270010057 | null | 54.6 | Palliative (P) | 2016-01-24 | 2016-02-01 | IGEV | 2 | N | 270017496 | PANITUMUMAB |
| 270019665 | 270010068 | null | 96.4 | Palliative (P) | 2019-02-05 | 2019-03-06 | GDP | 02 | N | 270017507 | GDP |
| 270019666 | 270017114 | 1.77 | 58.8 | Disease modification (D) | null | 2016-05-02 | Gemcitabine + Methylprednisolone | null | null | 270017577 | VEPEMB |
| 270019667 | 270010097 | 1.88 | null | Curative (C) | null | 2019-07-13 | CETUXIMAB + OXALIPLATIN + MDG | 1 | N | 270017792 | AFLIBERCEPT + FU + IRINOTECAN |
| 270019668 | 270010100 | 1.79 | 98.3 | Curative (C) | 2017-03-26 | 2017-08-29 | CISPLATIN + GEMCITABINE | 2 | N | 270017821 | NIVOLUMAB |
| 270019669 | 270010120 | null | 47 | Palliative (P) | 2017-10-27 | 2017-10-31 | Vinblastine | 2 | N | 270018100 | ABVD R |